Dx&Vx said Tuesday that it is launching a genomic big data provision service to start a full-fledged medical data business.Based on its genomic analysis database of 440,000 cases, the largest in Korea, Dx&Vx explained that it provides anonymized clinical genomic data to companies and research instit
The Celltrion Group announced the launch of the integrated entity of Celltrion and Celltrion Healthcare, in which Celltrion will be absorbing Celltrion Healthcare to form a single entity, on Thursday.The scheduled date for the listing of new shares resulting from this merger is Jan. 12, 2024, and se
CHA Biotech, a Kosdaq-listed cell therapy company, said Tuesday that it has signed a contract development and manufacturing organization (CDMO) agreement with Frombio, a Kosdaq-listed health functional food company, to develop stem cell therapy for hair loss.Under the accord, CHA Biotech will establ
AriBio said on Tuesday that it applied for a global phase 3 study of AR1001, an oral treatment candidate for Alzheimer’s disease, to the European Medicines Agency (EMA).The phase 3 trial, Polaris-AD, will enroll more than 400 patients with early Alzheimer’s disease in European countries including th
NGeneBio, a Kosdaq-listed precision diagnostics company, said Friday that it has obtained marketing authorization from the Thai Food and Drug Administration (TFDA) for Solidaccutest DNA, a solid cancer precision diagnostic panel based on next generation sequencing (NGS) technology.Solidaccutest DNA
HLB's extraordinary shareholders' meeting has approved the company’s transfer listing from the tech-heavy Kosdaq to the main bourse Kospi market.In a public filing Thursday, HLB said that the agenda, "The proposal to abolish the conditional listing on the Kosdaq market and transfer listing in the se
VaxCell-Bio said it has signed a tripartite convergence business agreement with Jeonnam Bio Research Center (JBRC) and Thermo Fisher Scientific Solutions LLC to organically cooperate throughout the entire cycle to develop innovative cell therapy drugs.The main areas of cooperation include the exchan
Helixmith, a Korean biotech company, is set to change its largest shareholder from CanariaBio M to Biosolution Co.According to a public filing by Helixmith on Thursday, Helixmith's board meeting entered into a management rights transfer contract with Biosolution, including a paid-in capital increase
Pinotbio said Thursday that it has signed a technology transfer agreement with ConjugateBio, a U.S.-based biotech company, for 10 drug targets for its antibody-drug conjugates (ADCs) platform.Under the agreement, Pinotbio will receive up to $250 million in total payments, including upfront and miles
ToolGen, a Kosdaq-listed gene editing company, said it has agreed to transfer its gene editing technology CRISPR-Cas9 to Nulla Bio, a crop genetic editing company.The cost for the technology transfer was not disclosed as per the agreement between the two companies.Through this agreement, Nulla Bio w
NGeneBio said Wednesday that the company has registered a domestic patent for its tuberculosis (TB) diagnostic technology based on next-generation sequencing (NGS) technology.The patent is the “Composition for gene amplification for detecting mycobacterium tuberculosis and determining drug resistanc
ABL Bio said Tuesday that it has submitted a protocol amendment to the U.S. FDA for its phase 1 clinical trial of ABL301 at higher doses.If the amended protocol wins the FDA’s approval, the company plans to conduct a single-ascending dose study and a multiple-ascending dose study at higher doses of
S.Biomedics said Monday that the patent regarding the “method for differentiating and manufacturing dopamine neuronal cells from stem cells” has won permission to be registered in Canada, following Japan, Australia, and the U.S.The patent is related to S. Biomedics’ core business and a key technolog
The Ministry of Food and Drug Safety (MFDS) said it imposed an administrative penalty equivalent to a 1.5-month suspension of clinical trials on Samsung Bioepis for violating regulatory requirements in conducting a clinical study.The clinical trial, "SB15-3001," was aimed to compare the efficacy, sa
ISU Abxis, a Kosdaq-listed biotech firm, said Thursday that it has applied for marketing authorization to sell Abcertin, a treatment for Gaucher disease, in Iraq.According to ISU Abxis, the Iraqi health authorities visited the company’s facility where Abcertin is manufactured to conduct GMP due dili
"The digital health market has been driven mainly by technology-driven decisions, and they have not thought much about how to convince doctors, patients, and insurance payers to provide a better user experience. To grow the market further, however, more people must have commercializing minds.”Hong S
LG Chem announced on Friday that it has received approval from the Korean Ministry of Food and Drug Safety (MFDS) for Xelenka, a Humira biosimilar for autoimmune disease treatment.This approval comes about a year after LG Chem applied for the approval in December last year.Xelenka is indicated for r
Geneomictree said Thursday that it has completed patient recruitment for its confirmatory clinical trial of EarlyTect-B, an in vitro diagnostic for bladder cancer.EarlyTect B is a new type of in vitro molecular diagnostic for the early detection of bladder cancer.According to Genomictree, EarlyTect-
EyeGene, a messenger ribonucleic acid (mRNA) vaccine developer, has ushered in BMI Korea as its new largest shareholder.The company is drawing attention by announcing that it will overhaul its R&D strategy from the ground up as it launches a new management structure early next year.On Wednesday, Eye
NeoImmuneTech, a Kosdaq-listed biotech firm, said on Tuesday it would provide its cancer immunotherapy candidate NT-17 to Imugene, an Australian immuno-oncology company, to conduct a study combining NT-I7 with the latter’s CAR-T cell therapy, Azer-cel.Initially, NeoImmuneTech will supply NT-17 at no
